- Home
- TIL vs MIST Comparison
TIL vs MIST Comparison
Compare TIL & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- MIST
- Stock Information
- Founded
- TIL 2018
- MIST 2003
- Country
- TIL United States
- MIST Canada
- Employees
- TIL N/A
- MIST N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- TIL Health Care
- MIST Health Care
- Exchange
- TIL Nasdaq
- MIST Nasdaq
- Market Cap
- TIL 230.1M
- MIST 89.8M
- IPO Year
- TIL 2021
- MIST N/A
- Fundamental
- Price
- TIL $23.64
- MIST $2.17
- Analyst Decision
- TIL Buy
- MIST Strong Buy
- Analyst Count
- TIL 5
- MIST 2
- Target Price
- TIL $119.00
- MIST $7.50
- AVG Volume (30 Days)
- TIL 350.9K
- MIST 638.1K
- Earning Date
- TIL 08-12-2025
- MIST 08-07-2025
- Dividend Yield
- TIL N/A
- MIST N/A
- EPS Growth
- TIL N/A
- MIST N/A
- EPS
- TIL N/A
- MIST N/A
- Revenue
- TIL N/A
- MIST N/A
- Revenue This Year
- TIL N/A
- MIST N/A
- Revenue Next Year
- TIL N/A
- MIST N/A
- P/E Ratio
- TIL N/A
- MIST N/A
- Revenue Growth
- TIL N/A
- MIST N/A
- 52 Week Low
- TIL $9.70
- MIST $0.63
- 52 Week High
- TIL $92.00
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- TIL 46.10
- MIST 74.51
- Support Level
- TIL $20.60
- MIST $1.86
- Resistance Level
- TIL $30.90
- MIST $1.97
- Average True Range (ATR)
- TIL 4.09
- MIST 0.12
- MACD
- TIL -0.99
- MIST 0.02
- Stochastic Oscillator
- TIL 21.11
- MIST 93.22
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).